DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 967 filers reported holding DANAHER CORPORATION in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $362,408,000 | +6.8% | 1,403,105 | +4.8% | 0.54% | +12.8% |
| Q2 2022 | $339,451,000 | -22.3% | 1,338,948 | -10.1% | 0.48% | -5.6% |
| Q1 2022 | $436,859,000 | +28.0% | 1,489,305 | +43.6% | 0.50% | +21.2% |
| Q4 2021 | $341,317,000 | +1.6% | 1,037,406 | -7.1% | 0.42% | -10.9% |
| Q3 2021 | $335,984,000 | +13.1% | 1,116,760 | +0.9% | 0.47% | +16.5% |
| Q2 2021 | $297,055,000 | +25.2% | 1,106,928 | +5.0% | 0.40% | +13.9% |
| Q1 2021 | $237,201,000 | -49.9% | 1,053,853 | -50.6% | 0.35% | -5.9% |
| Q4 2020 | $473,696,000 | +104.7% | 2,132,418 | +98.4% | 0.37% | -12.0% |
| Q3 2020 | $231,447,000 | +16.5% | 1,074,846 | -4.4% | 0.42% | +5.5% |
| Q2 2020 | $198,736,000 | +23.1% | 1,123,881 | -3.6% | 0.40% | +2.5% |
| Q1 2020 | $161,434,000 | -35.3% | 1,166,304 | -28.3% | 0.39% | -19.6% |
| Q4 2019 | $249,702,000 | -8.3% | 1,626,917 | -13.8% | 0.49% | -16.4% |
| Q3 2019 | $272,437,000 | +0.3% | 1,886,295 | -0.8% | 0.58% | -1.7% |
| Q2 2019 | $271,720,000 | -2.5% | 1,901,208 | -9.9% | 0.60% | -6.9% |
| Q1 2019 | $278,642,000 | +20.1% | 2,110,604 | -6.2% | 0.64% | +6.0% |
| Q4 2018 | $232,076,000 | -4.9% | 2,250,543 | +0.2% | 0.60% | +11.3% |
| Q3 2018 | $244,058,000 | +9.0% | 2,246,073 | -1.0% | 0.54% | +1.7% |
| Q2 2018 | $223,837,000 | -52.5% | 2,268,309 | -52.9% | 0.53% | -8.9% |
| Q1 2018 | $471,420,000 | +136.5% | 4,814,846 | +124.2% | 0.58% | +21.1% |
| Q4 2017 | $199,334,000 | +36.9% | 2,147,534 | +26.5% | 0.48% | +28.5% |
| Q3 2017 | $145,579,000 | +6.5% | 1,697,124 | +4.8% | 0.38% | +4.7% |
| Q2 2017 | $136,633,000 | +18.8% | 1,619,070 | +20.4% | 0.36% | +16.2% |
| Q1 2017 | $114,993,000 | +49.5% | 1,344,478 | +36.1% | 0.31% | +42.4% |
| Q4 2016 | $76,898,000 | -4.5% | 987,902 | -3.8% | 0.22% | -6.5% |
| Q3 2016 | $80,527,000 | -13.0% | 1,027,262 | +12.0% | 0.23% | -14.1% |
| Q2 2016 | $92,603,000 | +7.2% | 916,858 | +0.7% | 0.27% | +1.5% |
| Q1 2016 | $86,381,000 | -8.2% | 910,619 | -10.1% | 0.27% | -4.7% |
| Q4 2015 | $94,067,000 | +25.0% | 1,012,781 | +14.7% | 0.28% | +20.3% |
| Q3 2015 | $75,269,000 | -48.4% | 883,338 | -48.2% | 0.23% | -48.0% |
| Q2 2015 | $145,948,000 | +7.9% | 1,705,197 | +7.0% | 0.45% | +9.6% |
| Q1 2015 | $135,305,000 | -15.8% | 1,593,693 | -15.0% | 0.41% | -14.1% |
| Q4 2014 | $160,764,000 | -14.2% | 1,875,679 | -23.9% | 0.47% | -15.1% |
| Q3 2014 | $187,287,000 | -50.5% | 2,464,948 | -48.8% | 0.56% | -0.4% |
| Q2 2014 | $378,680,000 | +195.9% | 4,809,844 | +181.9% | 0.56% | +48.5% |
| Q1 2014 | $127,971,000 | +84.2% | 1,706,285 | +89.6% | 0.38% | +89.4% |
| Q4 2013 | $69,484,000 | -25.8% | 900,047 | -33.4% | 0.20% | -29.2% |
| Q3 2013 | $93,653,000 | -0.7% | 1,351,029 | -9.4% | 0.28% | -1.7% |
| Q2 2013 | $94,352,000 | – | 1,490,557 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |